טוען...
VEGF-A Is Necessary and Sufficient for Retinal Neuroprotection in Models of Experimental Glaucoma
Vascular endothelial growth factor A (VEGF-A) is a validated therapeutic target in several angiogenic- and vascular permeability–related pathological conditions, including certain cancers and potentially blinding diseases, such as age-related macular degeneration and diabetic retinopathy. We and oth...
שמור ב:
Main Authors: | , , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
American Society for Investigative Pathology
2013
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3608027/ https://ncbi.nlm.nih.gov/pubmed/23416159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2012.12.032 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|